To conclude, the expression of CD34 is not associated with other prognostic markers in B-ALL while absence of CD34 is associated with aberrant immunophenotypic expression of markers (myeloid + T-cell antigens) in B-ALL. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.